What is Umoja Biopharma worth?
$420.0Mlast known valuation
Umoja Biopharma last raised $210.0M in its Later Stage VC (Jun 2021).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 25 names
- ·Watchlist + deal alerts for Umoja Biopharma
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2021 | Later Stage VC | $210.0M | ▮ | ▮ |
How Umoja Biopharma's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Umoja Biopharma, we compose those signals into the PA Mark — a weighted composite of 1 recent pricing inputs, decayed by age and reset on new rounds. The implied valuation multiplies the mark by shares outstanding. Full methodology →
Frequently asked
- What is Umoja Biopharma worth?
- Umoja Biopharma's implied valuation is $420.0M, based on the PA Mark composite price of about $4 per share as of Sep 2026.
- How much has Umoja Biopharma raised?
- Umoja Biopharma has raised $371.0M in total funding across 1 recorded rounds.
- When did Umoja Biopharma last raise?
- Umoja Biopharma last raised in Jun 2021 (Later Stage VC), raising $210.0M.